id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-350972-0n4dumgg	Sing, Chor-Wing	Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors	2020-07-16		.txt	text/plain	1789	143	59	title: Long-term outcome of short-course high-dose glucocorticoids for SARS: a 17-year follow-up in SARS survivors Results showed that high-dose glucocorticoids greatly increased long-term risk of avascular necrosis, but not other major diseases. Hong Kong had an outbreak of severe acute respiratory syndrome (SARS; caused by SARS-CoV-1) in 2003, resulting in 1,755 cases and 299 deaths 3 Short course of very-high-dose (VHD) glucocorticoids was used for the treatment of SARS, especially to prevent cytokine storm. To understand the long-term consequences of VHD glucocorticoids, we studied the clinical outcomes of SARS survivors after 17 years. We identified SARS survivors using an electronic medical record database, Clinical Data Analysis and Reporting System (CDARS) of the Hong Kong Hospital Authority, the details of which have been described elsewhere. In this retrospective study of SARS survivors with 17 years of follow-up, a short-course use of VHD glucocorticoids was not associated with major diseases except AVN.	./cache/cord-350972-0n4dumgg.txt	./txt/cord-350972-0n4dumgg.txt